Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans

Metabolism: Clinical and Experimental

Volumn 47, Issue 1, 1998, Pages 7-12

  Frank, J W ^a   Camilleri, M ^a   Thomforde, G M ^a   Dinneen, S F ^a   Rizza, R A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLECYSTOKININ; GASTROINTESTINAL POLYPEPTIDE; GLUCAGON; GLUCOSE; INSULIN; NEUROTENSIN; PEPTIDE YY;

ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH EMPTYING;

EID: 0031908153     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90185-8     Document Type: Article

References (34)

1. Liljenquist JE, Mueller GL, Cherrington AD, et al: Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest 59:369-374, 1977
2. Felig P, Wahren J, Hendler R: Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. J Clin Invest 58:761-765, 1976
3. Lins P, Wajngot A, Adamson U, et al: Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia. Diabetes 32:633-636, 1983
4. Myers SR, Diamond MP, Adkins-Marshall BA, et al: Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp. Metabolism 40:66-71, 1991
5. Rizza RA, Gerich JE: Persistent effect of sustained hyperglucagonemia on glucose production in man. J Clin Endocrinol Metab 48:352-355, 1979
6. Fradkin J, Shamoon H, Felig P, et al: Evidence for an important role of changes in, rather than absolute concentrations of, glucagon in the regulation of glucose production in humans. J Clin Endocrinol Metab 50:698-703, 1980
7. Steiner KE, Mouton SM, Bowles CR, et al: The relative importance of first- and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog. Diabetes 31:964-972, 1982
8. Liljenquist JE, Rabin D: Lack of a role for glucagon in the disposal of an oral glucose load in normal man. J Clin Endocrinol Metab 49:937-939, 1979
9. Schjoldager B, Lawaetz O, Chirstiansen J: Effect of pancreatic glucagon and its 1-21 fragment on gastric emptying in man. Scand J Gastroenterol 23:726-730, 1988
10. Bell T, Malagelada J: Glucagon-evoked gastric dysrhythmias in humans shown by an improved electrogastrographic technique. Gastroenterology 88:1932-1940, 1985
11. Chernish S, Brunelle R, Rosenak B, et al: Comparison of the effects of glucagon and atropine sulfate on gastric emptying. Am J Gastroenterol 70:581-586, 1978
12. Gregersen H, Rittig S, Kraglund K, et al: The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Scand J Gastroenterol 23:42-47, 1988
13. Jonderko G, Golab T, Jonderko K: A pharmacological dose of glucagon suppresses gastric emptying of a radiolabelled solid meal in humans. Scand J Clin Invest 48:743-746, 1988
14. Bellahsene B, Lind CD, Schinner BD, et al: Acceleration of gastric emptying with electrical stimulation in a canine model of gastroparesis. Am J Physiol 262:G826-G834, 1992
15. 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 126:126-132, 1996
16. Frank JW, Camilleri M, Thomforde GM, et al: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 109:755-765, 1995
17. Camilleri M, Malagelada J, Brown ML, et al: Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 249:G580-G585, 1985
18. SAS Institute: Statistics, in SAS User's Guide. Cary, NC, SAS Institute, 1982, pp 297-308
19. 3H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used. J Clin Invest 78:1479-1486, 1986
20. Yaksh TL, Michener SR, Bailey JE, et al: Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, met-enkephalin, bombesin and PHI in the spinal cord of a cat, dog, sloth and monkey. Peptides 9:357-372, 1988
21. Firth RG, Bell PM, Marsh HM, et al: Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 77:1525-1532, 1986
22. Schick RR, Reilly WM, Roddy DR, et al: Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus. Brain Res 418:20-26, 1987
23. Service FJ, Rizza RA, Westland RE, et al: Gastric inhibitory polypeptide in obesity and diabetes mellitus. J Clin Endocrinol Metab 58:1133-1140, 1984
24. Steele R, Wall JS, De Bodo RC, et al: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
25. Butler RC, Rizza RA: Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 40:73-81, 1991
26. Dinneen S, Alzaid A, Turk D, et al: Failure of glucagon suppression contributes to postprandial hyperglycemia in IDDM. Diabetologia 38:337-343, 1995
27. Rolston DDK, Matham VI: Xylose transport in the human jejunum. Dig Dis Sci 34:553-558, 1989
28. Cook GC: Rates and mechanisms of glucose, galactose and xylose absorption in man in vivo. Scand J Gastroenterol 12:733-737, 1977
29. Lochenvitz E, Schunlle PO, Hanisch E, et al: Influence of exogenous glucagon in gastric acid secretion, mucosal blood flow, and stress ulcers in the rat: Dose-response results under non-stress conditions and immobilization stress. Res Exp Med 182:245-253, 1983
30. Paolisso G, Scheen AJ, Luyckx AS, et al: Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man. Am J Physiol 252:E1-E7, 1987
31. Dinneen S, Gerich J, Rizza R: Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327:707-713, 1992
32. Pfeifer MA, Samols E, Wolter CF, et al: Low-dose versus high-dose insulin therapy for diabetic ketoacidosis. South Med J 72:149-154, 1979
33. Burghen GA, Etteldorf JN, Fisher JN, et al: Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care 3:15-20, 1980
34. Werb MR, Zinman B, Teasdale SJ, et al: Hormonal and metabolic responses during coronary artery bypass surgery: Role of infused glucose. J Clin Endocrinol Metab 69:1010-1018, 1989